Lilly’s GLP-1 medications will soon be covered by CVS, potentially opening access for millions of Americans
That means millions more Americans may get access to Lilly’s new GLP-1 pill Foundayo or the GLP-1 injection Zepbound...
Market Touch Signal is a free discovery window from Oy Market Touch Ltd.
Practical intelligence, clear communication and useful digital ventures: https://market-touch.org/